These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17397360)

  • 1. A case of porphyria cutanea tarda resulting in digital amputation and improved by anastrazole.
    Roche M; Daly P; Crowley V; Darby C; Barnes L
    Clin Exp Dermatol; 2007 May; 32(3):327-8. PubMed ID: 17397360
    [No Abstract]   [Full Text] [Related]  

  • 2. Symptomatic porphyria cutanea tarda and B-immunoblastic lymphoma: is there an association?
    Younossi ZM; Pockros PJ
    Am J Hematol; 1996 Mar; 51(3):252-3. PubMed ID: 8619418
    [No Abstract]   [Full Text] [Related]  

  • 3. Porphyria cutanea tarda induced by tamoxifen.
    Cruz MJ; Alves S; Baudrier T; Azevedo F
    Dermatol Online J; 2010 Sep; 16(9):2. PubMed ID: 20875323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer.
    Bertoli LF; Barton JC
    Clin Breast Cancer; 2007 Aug; 7(9):716-8. PubMed ID: 17919354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An epidemic of porphyria cutanea tarda?
    Brashear R; Began D; Petersen J; Chuang TY
    Int J Dermatol; 2000 Feb; 39(2):154-6. PubMed ID: 10692068
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of brain metastases from breast cancer that responded to anastrozole monotherapy.
    Ito K; Ito T; Okada T; Watanabe T; Gomi K; Kanai T; Mochizuki Y; Amano J
    Breast J; 2009; 15(4):435-7. PubMed ID: 19470131
    [No Abstract]   [Full Text] [Related]  

  • 7. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden.
    Linde Y; Harper P; Floderus Y; Ros AM
    Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Porphyria cutanea tarda after antineoplastic drugs].
    Malina L; Michalíková H; Hussarová L
    Cas Lek Cesk; 1999 Aug; 138(17):536-8. PubMed ID: 10566234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of anastrazole on symptomatic uterine leiomyomata.
    Varelas FK; Papanicolaou AN; Vavatsi-Christaki N; Makedos GA; Vlassis GD
    Obstet Gynecol; 2007 Sep; 110(3):643-9. PubMed ID: 17766612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyria cutanea tarda.
    Christoph S; Hüttmann A; Dührsen U; Röth A
    Br J Haematol; 2010 Feb; 148(4):493. PubMed ID: 19622066
    [No Abstract]   [Full Text] [Related]  

  • 11. Coexistence of a systemic lupus erythematosus and porphyria cutanea tarda: case successfully improved by avoidance of sun exposure.
    Murata J; Shimizu T; Tateishi Y; Abe R; Shimizu H
    Int J Dermatol; 2006 Apr; 45(4):435-7. PubMed ID: 16650173
    [No Abstract]   [Full Text] [Related]  

  • 12. [Successful treatment of haemodialysis-related porphyria cutanea tarda with deferoxamine].
    Pitche P; Corrin E; Wolkenstein P; Revuz J; Bagot M
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):37-9. PubMed ID: 12605155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I (sporadic) porphyria cutanea tarda in a hemodialysis patient: a case report.
    Tarwater K; Misra S; Misra M
    Hemodial Int; 2008 Oct; 12 Suppl 2():S38-42. PubMed ID: 18837769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of myocardial infarct in latent porphyria cutanea tarda].
    Krivosheev AB
    Ter Arkh; 1997; 69(4):80-1. PubMed ID: 9213971
    [No Abstract]   [Full Text] [Related]  

  • 15. Porphyria cutanea tarda in a patient with HIV-infection.
    Almehmi A; Deliri H; Szego GG; Teague AC; Pfister AK; Martin SA
    W V Med J; 2005; 101(1):19-21. PubMed ID: 15861867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole.
    Karagöz B; Ayata A; Bilgi O; Uzun G; Unal M; Kandemir EG; Ozgün A; Türken O
    Onkologie; 2009 Jul; 32(7):421-3. PubMed ID: 19556821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extended adjuvant hormone therapy (in breast cancer): Why? To whom? What? How long?].
    Kahán Z
    Magy Onkol; 2008 Jun; 52(2):225-6. PubMed ID: 18640899
    [No Abstract]   [Full Text] [Related]  

  • 18. Provocation of porphyria cutanea tarda by KUVA-therapy of vitiligo.
    Jansen T; Megahed M; Hölzle E; Plewig G
    Acta Derm Venereol; 1995 May; 75(3):232-3. PubMed ID: 7653185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porphyria cutanea tarda induced by estrogens.
    Becker FT
    Arch Dermatol; 1965 Sep; 92(3):252-5; discussion 255-6. PubMed ID: 11851245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda.
    Giunta A; Demin F; Campione E; Chimenti S; Bianchi L
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):849-50. PubMed ID: 19207637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.